loading
전일 마감가:
$2.90
열려 있는:
$2.89
하루 거래량:
51,505
Relative Volume:
0.43
시가총액:
$14.30M
수익:
-
순이익/손실:
$-43.10M
주가수익비율:
-0.2985
EPS:
-9.7212
순현금흐름:
$-36.82M
1주 성능:
+13.57%
1개월 성능:
-2.01%
6개월 성능:
-62.24%
1년 성능:
-76.02%
1일 변동 폭
Value
$2.82
$2.99
1주일 범위
Value
$2.5811
$3.15
52주 변동 폭
Value
$2.40
$12.61

Tempest Therapeutics Inc Stock (TPST) Company Profile

Name
명칭
Tempest Therapeutics Inc
Name
전화
415-798-8589
Name
주소
2000 SIERRA POINT PARKWAY, BRISBANE
Name
직원
5
Name
트위터
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
TPST's Discussions on Twitter

TPST을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TPST
Tempest Therapeutics Inc
2.9019 14.29M 0 -43.10M -36.82M -9.7212
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.68 120.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
769.02 80.15B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
862.87 51.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
357.56 47.74B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.04 37.38B 4.98B 69.59M 525.67M 0.5197

Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-01-22 업그레이드 H.C. Wainwright Neutral → Buy
2025-04-10 다운그레이드 H.C. Wainwright Buy → Neutral
2025-04-10 다운그레이드 Scotiabank Sector Outperform → Sector Perform
2024-03-14 개시 Scotiabank Sector Outperform
2024-02-08 개시 Jefferies Buy

Tempest Therapeutics Inc 주식(TPST)의 최신 뉴스

pulisher
Jan 25, 2026

Investment Report: Is Tempest Therapeutics Inc stock a value trapJuly 2025 Final Week & Daily Stock Trend Watchlist - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 25, 2026

Aug Decliners: Is Tempest Therapeutics Inc stock a top performer YTD2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 22, 2026

Tempest Therapeutics stock surges after H.C. Wainwright upgrade By Investing.com - Investing.com South Africa

Jan 22, 2026
pulisher
Jan 22, 2026

H.C. Wainwright upgrades Tempest Therapeutics stock rating to Buy with $11 target - Investing.com India

Jan 22, 2026
pulisher
Jan 22, 2026

HC Wainwright & Co. Upgrades Tempest Therapeutics (TPST) - Nasdaq

Jan 22, 2026
pulisher
Jan 20, 2026

Inflation Data: Will Tempest Therapeutics Inc stock recover after earningsJuly 2025 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 20, 2026

Tempest Therapeutics Announces Record Date for Warrant Dividends Distribution Following Asset Purchase Agreement - Quiver Quantitative

Jan 20, 2026
pulisher
Jan 20, 2026

Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders - GlobeNewswire

Jan 20, 2026
pulisher
Jan 20, 2026

Cancer drug developer Tempest to hand out 1:1 stock warrants - Stock Titan

Jan 20, 2026
pulisher
Jan 19, 2026

How risky is Tempest Therapeutics Inc. stock nowCEO Change & Precise Buy Zone Tips - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 19, 2026

Will Tempest Therapeutics Inc. stock pay special dividendsJuly 2025 Institutional & Entry Point Confirmation Signals - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 18, 2026

Sentiment Review: Can Tempest Therapeutics Inc reach all time highs this yearPortfolio Update Report & Community Driven Trade Alerts - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 13, 2026

Is Tempest Therapeutics Incs growth already priced inWeekly Trend Recap & Daily Profit Focused Screening - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Published on: 2026-01-13 20:12:45 - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 09, 2026

Tempest Therapeutics receives Nasdaq notice for annual meeting compliance By Investing.com - Investing.com Canada

Jan 09, 2026
pulisher
Jan 09, 2026

Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting - TipRanks

Jan 09, 2026
pulisher
Jan 09, 2026

Tempest Therapeutics receives Nasdaq notice for annual meeting compliance - Investing.com India

Jan 09, 2026
pulisher
Jan 09, 2026

Tempest Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets

Jan 09, 2026
pulisher
Jan 09, 2026

Why retail investors favor Tempest Therapeutics Inc. stockJuly 2025 Chart Watch & High Win Rate Trade Tips - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Will Tempest Therapeutics Inc. stock split again soonJuly 2025 Update & Fast Momentum Stock Entry Tips - Улправда

Jan 08, 2026
pulisher
Dec 30, 2025

Tempest Therapeutics, Inc.Common Stock (NQ: TPST - FinancialContent

Dec 30, 2025
pulisher
Dec 29, 2025

Market Outlook: Will Tempest Therapeutics Inc stock pay special dividendsJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - moha.gov.vn

Dec 29, 2025
pulisher
Dec 26, 2025

Tempest Therapeutics (TPST) Stock Price, Quote, News & History - Benzinga

Dec 26, 2025
pulisher
Dec 22, 2025

Will Tempest Therapeutics Inc. stock beat EPS estimatesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - bolumsonucanavari.com

Dec 22, 2025
pulisher
Dec 19, 2025

How sustainable is Tempest Therapeutics Inc. stock dividend payout2025 Winners & Losers & Verified Momentum Stock Alerts - Улправда

Dec 19, 2025
pulisher
Nov 27, 2025

Tempest Therapeutics closes $4.25 million registered direct offering By Investing.com - Investing.com India

Nov 27, 2025
pulisher
Nov 26, 2025

Tempest Therapeutics Closes $4.3 Million Direct Offering - MarketScreener

Nov 26, 2025
pulisher
Nov 26, 2025

Tempest Therapeutics closes $4.25 million registered direct offering - Investing.com

Nov 26, 2025
pulisher
Nov 26, 2025

Tempest Therapeutics : Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules - MarketScreener

Nov 26, 2025
pulisher
Nov 26, 2025

Tempest Therapeutics, Inc. Completes Registered Direct Offering and Private Placement, Raising Approximately $4.25 Million - Quiver Quantitative

Nov 26, 2025
pulisher
Nov 26, 2025

Tempest Announces Closing of Up To $8.35 Million Registered - GlobeNewswire

Nov 26, 2025
pulisher
Nov 26, 2025

[8-K] Tempest Therapeutics, Inc. Reports Material Event | TPST SEC FilingForm 8-K - Stock Titan

Nov 26, 2025
pulisher
Nov 25, 2025

Form 8-KCurrent report - ADVFN

Nov 25, 2025
pulisher
Nov 25, 2025

Tempest Therapeutics stock falls after $4.25 million direct offering - MSN

Nov 25, 2025
pulisher
Nov 25, 2025

[424B5] Tempest Therapeutics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan

Nov 25, 2025
pulisher
Nov 25, 2025

Form 424B5 Tempest Therapeutics, - StreetInsider

Nov 25, 2025
pulisher
Nov 25, 2025

Tempest Therapeutics stock falls after $4.25 million direct offering By Investing.com - Investing.com UK

Nov 25, 2025
pulisher
Nov 25, 2025

Tempest Therapeutics raises $4.25 million in registered direct offering - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

Tempest Therapeutics Inc (TPST) Performance and Fundamentals Dashboard tells a completely different story - setenews.com

Nov 25, 2025
pulisher
Nov 25, 2025

Tempest Therapeutics raises $4.25 million in registered direct offering By Investing.com - Investing.com India

Nov 25, 2025
pulisher
Nov 25, 2025

Tempest Therapeutics (Nasdaq: TPST) prices $4.25M offering with $4.1M warrant upside - Stock Titan

Nov 25, 2025

Tempest Therapeutics Inc (TPST) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$100.00
price up icon 2.27%
$104.19
price up icon 1.52%
$34.40
price up icon 2.76%
$119.02
price up icon 0.84%
$163.94
price up icon 2.66%
biotechnology ONC
$335.75
price down icon 0.46%
자본화:     |  볼륨(24시간):